by Baker McKenzie

Why healthtech gets our pulses racing

With healthcare providers turning to digital to meet consumer demands, an increasing convergence of healthcare and tech companies could restore M&A activity for 2019. But is this emerging healthtech sector immune to global uncertainty?


You might like this

Why the tech giants have CEOs running scared

Due Diligence’s James Fontanella-Khan, US corporate finance and deals editor, explains why established companies from brick and mortar retailers to broadcasters are taking risky bets on big acquisitions.

For the background to this video here is some additional reading from the FT archive:

November 10 2017: Media landscape in tumult with deal talk rife

Jan 11 2018: Big pharma raises bet on biotech as frontier for growth

January 31 2018: Amazon makes its move in healthcare

March 20 2018: AT&T’s case to create a rival to Netflix and Amazon

February 26 2019: US court backs AT&T’s acquisition of Time Warner

Discover more content on the topics that inspire, engage and inform the world we live in today at the FT Channels hub.